Table 2.

Characteristics of patients with COVID-19.

Patient N	1	2	3	4	5	6	7
Gender	M	F	M	F	F	F	F
Age (year)	60	72	78	81	79	60	40
ECOG PS	1	2	2	1	2	1	3
Cancer type	Colorectal	Gastric	Prostate	Breast	Renal cell carcinoma	Neuroendocrine pancreatic tumor	Breast
Stage	Metastatic	Metastatic	Metastatic	Early	Metastatic	Metastatic	Metastatic
Metastatic site	Liver, lymph node, lung	Liver, lymph nodes, lung	Bone, liver	//	Lung, lymph node	Liver	Liver, lymph nodes,
Setting of treatment	First line	First line	Second line	Adjuvant	Second line	Second line	Fourth line
Active treatment	Oxaliplatin Fluorouracil Leucovorin	Cisplatin, Capecitabine, Trastuzumab	Enzalutamide Denosumab	Paclitaxel	Nivolumab	Everolimus	Exemestane plus everolimus
Comorbidities Number	4	4	4	2	2	2	0
Type of comorbidities	Blood hypertension, cardiac and renal failure, rheumatoid arthritis	Blood hypertension, hypothyroidism, HCV-related liver disease, heart transplant for dilated cardiomyopathy	Acute myocardial ischemia, chronic obstructive pulmonary disease, dyslipidemia, diabetes mellitus	Blood hypertension, osteoporosis	Blood hypertension, cerebral ischemia	Blood hypertension, diabetes mellitus	//
Hospitalized (yes/no)	Yes	Yes	Yes	Yes	Yes	No	No
COVID-19 status	Died	Died	Died	Resolved	Died	Resolved	Died *

Abbreviations: ECOG PS: Eastern Cooperative Oncology Group Performance Status; F, female; HCV, hepatitis C virus; M, male; N, number * Died of disease progression and not from COVID-19.